The Claim
Thyroid epithelial cells in patients with Hashimoto's thyroiditis or Graves disease ectopically express MHC class II molecules, which are absent in healthy thyroid tissue and normally restricted to professional antigen-presenting cells.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In people with Hashimoto's thyroiditis or Graves disease, thyroid cells produce MHC class II molecules that are not found in healthy thyroid tissue and are typically only produced by specialized immune cells.
See the scientific wording
Thyroid epithelial cells in patients with Hashimoto’s thyroiditis or Graves disease can ectopically express MHC class II molecules, which are not typically present in healthy thyroid tissue and are normally restricted to professional antigen-presenting cells.
In diseased thyroid tissue, the cells that normally make thyroid hormones start displaying immune system markers called MHC class II molecules. These markers let the cells show fragments of thyroid proteins to immune cells called CD4+ T cells, which then activate and attack the thyroid tissue. This process does not happen in healthy thyroid tissue.
What the research says
1 studyStudy: MON-425 Defining Disease-Specific Epithelial Cell Phenotypes in Thyroid Autoimmunity
In people with Hashimoto’s or Graves disease, some thyroid cells start acting like immune cells by displaying MHC class II proteins — which healthy thyroid cells never do. This study proved that by examining thyroid tissue from patients and finding these immune-like proteins only in diseased cells.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.